ArticleNature cancer2026

Tumor-localized CD40 agonism with MP0317, a FAP x CD40 DARPin, reprograms the tumor microenvironment in patients with advanced solid tumors: an open-label, nonrandomized, dose-escalation phase 1 study.

Neeltje Steeghs et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.